Kimberly-Clark offers bonds to help fund Tylenol maker takeover


Kenvue has struggled financially since being spun off from Johnson & Johnson in 2023, and the company found itself battling with the Trump administration last year over the safety of its biggest product, Tylenol. Its portfolio also includes Neutrogena lotion, Listerine mouthwash, Benadryl allergy medicine and Band-Aid wound care products.



Source link

  • Related Posts

    Quebec’s reserves of maple syrup almost depleted, says new report

    Listen to this article Estimated 4 minutes The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review…

    Continue reading
    GoldInxs Mining Corp. Closes Second Tranche of Upsized Non-Brokered Private Placement and Announces Board Changes

    About GoldInxs Read More Source link

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Quebec’s reserves of maple syrup almost depleted, says new report

    Quebec’s reserves of maple syrup almost depleted, says new report

    Here’s How We Would Build Out The Perfect Modular Electric Slate Truck

    Here’s How We Would Build Out The Perfect Modular Electric Slate Truck

    NFL suspends CJ Gardner-Johnson 1 game for spitting at Brock Bowers

    NFL suspends CJ Gardner-Johnson 1 game for spitting at Brock Bowers

    GoldInxs Mining Corp. Closes Second Tranche of Upsized Non-Brokered Private Placement and Announces Board Changes

    Statement on the meeting of the IHR Emergency Committee for Ebola virus disease in the Democratic Republic of the Congo

    Statement on the meeting of the IHR Emergency Committee for Ebola virus disease in the Democratic Republic of the Congo

    New AI Tool Could Help Scientists Make ‘Rare’ Cross-Disciplinary Leaps More Common

    New AI Tool Could Help Scientists Make ‘Rare’ Cross-Disciplinary Leaps More Common